Bestclinicabroad
Connect with the world's Best Clinic and doctors at Best Clinic Abroad. Your well-being is our priority, with personalized care every step of the way.
Connect with the world's Best Clinic and doctors at Best Clinic Abroad. Your well-being is our priority, with personalized care every step of the way.
26 Rue d'Ulm, 75005 Paris, FranceFounded in 1909 by Marie Curie, the Institut Curie is internationally recognized for its expertise in oncology, offering a multidisciplinary approach that integrates research, diagnosis, and treatment. The hospital specializes in treating all types of cancer, including rare and complex cases, ensuring comprehensive and personalized care for each patient. With a strong commitment to innovation and excellence, it serves both local and international patients.
Key Services at Institut Curie:
Institut Curie remains a pioneer in oncology, combining advanced research, advanced treatments, and compassionate patient care, making it a preferred destination for cancer treatment worldwide.
-2.avif&w=2048&q=75)
Georges-Pompidou European Hospital 20 Rue Leblanc, 75015 ParisLocated in Paris’s 15th arrondissement (20 rue Leblanc), HEGP was built by merging the historic Boucicaut, Broussais, Laënnec, and Rothschild hospitals. Designed by architect Aymeric Zublena, it is a modern cornerstone of French medicine, with specialized clinical poles in cardiovascular, cancer, and emergencies.
HEGP is internationally recognized as a leading center for cardiac surgery, including the implantation of the first 100% artificial heart in December 2013. It also excels in oncology, nephrology, rare vascular and genetic diseases, emergency medicine, and multidisciplinary care, all backed by strong academic and research frameworks.
Advanced Technology & Facilities
Key Services at HEGP
Hôpital Européen Georges‑Pompidou is an advanced, research-driven university hospital offering world-class care across cardiovascular, oncologic, renal, surgical, neurological, and emergency specialties backed by digital innovation, multidisciplinary teams, and international referrals.
480 avenue David Ben Gourion - 69009 LyonLocated in the 9th arrondissement of Lyon, Clinique de la Sauvegarde is a well-established multidisciplinary hospital under the Ramsay Santé group, one of France’s leading private healthcare networks. The clinic is recognized for its surgical precision, modern medical infrastructure, and patient-centered care. Strategically positioned in a quiet, residential district, the clinic offers both inpatient and outpatient treatments across a broad range of specialties, including orthopedics, cardiology, neurosurgery, oncology, and ophthalmology. It is particularly noted for its excellence in spine surgery, joint replacements, and minimally invasive procedures.
Clinique de la Sauvegarde is committed to combining advanced clinical expertise with personalized care pathways, ensuring seamless medical journeys for both French and international patients. As a part of a certified and accredited healthcare network, the clinic adheres to strict quality standards and is equipped with emergency capabilities, a recovery unit, and a 24/7 intensive care ward.
Advanced Technology & Facilities
Key Services at Clinique de la Sauvegarde
Clinique de la Sauvegarde remains a benchmark of modern private healthcare in Lyon, merging clinical excellence with personalized patient care across key medical and surgical specialties. It continues to attract patients seeking high-quality medical attention, advanced diagnostic solutions, and a trustworthy medical experience in one of France’s leading urban medical centers.
47–83 Boulevard de l’Hôpital, 75013 Paris, FranceLocated in Paris’s 13th arrondissement, Hôpital Universitaire Pitié‑Salpêtrière is one of Europe’s most renowned academic medical centers. Affiliated with Assistance Publique – Hôpitaux de Paris (AP‑HP) and Sorbonne University, it serves as a major hub for clinical care, teaching, and biomedical research. Known for its historical legacy in neurology, through figures like Jean-Martin Charcot, the hospital today spans more than 90 buildings and specializes in complex, high-risk care for adults. With over 50 specialty units and internationally recognized departments in neurology, cardiology, oncology, and surgery, Pitié‑Salpêtrière treats a large volume of critically ill and international patients. The hospital also houses specialized centers for organ transplantation, reproductive medicine, robotic surgery, and rare diseases, offering advanced care in both acute and chronic conditions. Recognized for its strong academic backbone and innovation, it is a frequent destination for cross-border patients seeking highly specialized medical treatment in France.
Advanced Technology & Facilities
Key Services at Hôpital Pitié‑Salpêtrière
With its unmatched clinical depth, advanced technology, and legacy of medical excellence, Hôpital Pitié‑Salpêtrière stands as a pillar of advanced healthcare in Europe. International patients choose it for its integrated, multidisciplinary expertise and high success rates in complex treatments. From critical care to specialized surgery, the hospital offers world-class solutions in the heart of Paris.
125 Rue d’Avron, 75020 Paris, FranceDiaconesses Croix Saint-Simon Hospital Group, based in Paris, is one of the largest non-profit private hospitals in eastern Paris, providing high-quality medical and surgical care across a wide range of specialties. The hospital combines a strong tradition of patient-focused healthcare with advanced medical technologies and recognized expertise in areas such as oncology, orthopedics, digestive surgery, fertility, geriatrics, and emergency medicine. With more than 400 specialists, modern facilities, and dedicated centres of excellence, it serves thousands of local and international patients each year.
The hospital emphasizes patient well-being by integrating medical treatment, surgical innovation, and supportive therapies. Accredited as an ESPIC institution, it reinvests all resources into upgrading staff, equipment, and services to ensure the highest level of care. With multilingual support, personalized treatment plans, and national recognition in several specialties, Diaconesses Croix Saint-Simon has become a trusted destination for comprehensive healthcare in France.
Advanced Technology & Facilities
Key Services
France provides hematology and oncology care within a highly regulated national healthcare system designed to ensure patient safety, clinical governance, and ethical medical practice. Cancer care is overseen by the French Ministry of Health and structured in alignment with European Union healthcare regulations, with national cancer plans guiding standards of diagnosis, treatment delivery, and institutional accountability. In recent years, hematology oncology services in France have continued to modernize through the integration of precision diagnostics, molecular pathology, advanced imaging, targeted systemic therapies, immunotherapy protocols, and updated multidisciplinary care models that reflect current international oncology practice rather than historical approaches.
Hematologists and oncologists in France follow clearly defined education, certification, and licensing pathways. Physicians complete a university medical degree followed by competitive national residency training in hematology, medical oncology, or radiation oncology, depending on specialization. Many pursue additional subspecialty training in areas such as hematologic malignancies, stem cell transplantation, or solid tumor oncology within university hospitals. Licensure is granted only after completion of nationally regulated examinations and supervised clinical practice. Continuous professional development is mandatory, with specialists participating in continuing medical education, clinical research, and international oncology conferences to maintain alignment with evidence-based standards.
Hematology oncology services are primarily delivered through large university-affiliated hospitals, comprehensive cancer centers, and specialized oncology institutes with tertiary-care capacity. These institutions are equipped with advanced diagnostic laboratories, radiology and nuclear medicine units, chemotherapy day-care facilities, bone marrow transplantation units, and intensive care support. Academic affiliation supports clinical research, specialist training, and collaboration across hematology, oncology, radiology, pathology, surgery, and supportive care services. This integrated infrastructure is a central feature of cancer care delivery in France.
For international patients, there are practical considerations that commonly arise at the outset. Patients typically begin exploring treatment options by contacting hospital international patient departments or medical travel facilitators to request general information about services, timelines, and documentation requirements. In practice, hospitals commonly request pathology reports, biopsy results, imaging studies, laboratory data, and prior treatment summaries to support an initial review. Communication with international patient offices is often conducted via email or secure digital platforms and focuses on coordination, documentation, and scheduling rather than clinical decision-making.
Foreign patients also frequently ask about visa or entry requirements related to medical travel, expected treatment duration, and the length of hospital or outpatient stays. While many oncology treatments are delivered on an outpatient basis, certain hematologic therapies or transplantation procedures may require prolonged stays, often exceeding 14 days. Language support is another common concern; many major cancer centers offer English-speaking staff or professional medical interpreters, though availability varies by institution. Planning for follow-up care after returning home is widely recognized as an essential component of responsible oncology care coordination.
Hematology oncology care in France reflects the adoption of modern diagnostic and therapeutic technologies within structured clinical governance frameworks. Hospitals routinely utilize digital diagnostics, molecular and cytogenetic testing, advanced imaging such as PET-CT, and precision laboratory platforms to support diagnostic accuracy and disease classification. Treatment planning is commonly conducted through multidisciplinary tumor boards, ensuring coordinated input from hematologists, oncologists, radiologists, pathologists, and other specialists.
Strict national protocols govern infection control, chemotherapy preparation and administration, imaging and radiation safety, and anesthesia management for interventional procedures. Post-treatment monitoring and follow-up are structured through scheduled assessments, laboratory monitoring, and clinical documentation to support patient safety and continuity of care. Supportive care services, including transfusion medicine and symptom management, are integrated within regulated institutional pathways.
Continuous professional development is a core requirement for hematology oncology specialists practicing in France. Participation in international oncology and hematology conferences, continuing medical education programs, and clinical research initiatives is common. Treatment plans are individualized, informed consent is required, and final clinical decisions depend on professional evaluation. At a national level, France is widely recognized for its emphasis on regulation, innovation, and patient safety in cancer care.
Chemotherapy
Chemotherapy is used to manage a wide range of solid tumors and hematologic malignancies. In France, chemotherapy administration follows standardized protocols, with dosing and scheduling based on diagnostic findings and clinical evaluation. Treatment is delivered in regulated hospital or outpatient settings with strict oversight for medication safety, infection control, and patient monitoring.
Immunotherapy
Immunotherapy involves the use of agents that modulate the immune system to target cancer cells. Diagnostic planning typically includes molecular and immunologic testing to characterize disease features. Administration is conducted under established safety protocols, with structured monitoring for treatment-related effects.
Targeted Therapy
Targeted therapy focuses on specific molecular or genetic characteristics of cancer cells. Diagnostic workflows often involve advanced laboratory testing and imaging. These therapies are delivered within regulated oncology units, emphasizing precision, safety, and careful follow-up.
Radiation Oncology
Radiation oncology uses high-energy radiation to treat malignant conditions. Treatment planning involves advanced imaging, computerized dose planning, and strict radiation safety standards. Delivery is overseen by specialized multidisciplinary teams within accredited cancer centers.
Bone Marrow and Stem Cell Transplantation
Bone marrow and stem cell transplantation are used in selected hematologic malignancies and disorders. Care pathways involve extensive diagnostic evaluation, donor matching where applicable, and prolonged monitoring. Procedures are performed in specialized transplant units with strict infection-control and supportive care protocols.
Supportive and Palliative Oncology Care
Supportive oncology care addresses symptom management, transfusion needs, and quality-of-life considerations alongside disease-directed therapy. These services are integrated within hematology oncology departments and delivered under regulated clinical governance frameworks.
Institut Gustave Roussy, Villejuif
Accreditations:
National oversight by the French Ministry of Health
University-affiliated cancer center
Specializations:
Provides comprehensive hematology and oncology services, including solid tumors, hematologic malignancies, advanced diagnostics, and multidisciplinary research-based care.
Hôpital Saint-Louis, Paris
Accreditations:
National oversight by the French Ministry of Health
University-affiliated teaching hospital
Specializations:
Specializes in hematology and oncology, including leukemia, lymphoma, and bone marrow transplantation, within a strong academic and research environment.
Hôpital Pitié-Salpêtrière, Paris
Accreditations:
National oversight by the French Ministry of Health
University-affiliated teaching hospital
Specializations:
Offers integrated oncology and hematology care supported by advanced imaging, clinical research, and multidisciplinary collaboration.
Hôpital Necker-Enfants Malades, Paris
Accreditations:
National oversight by the French Ministry of Health
University-affiliated teaching hospital
Specializations:
Provides pediatric and adult hematology oncology services, including rare blood disorders and complex malignancies, within a regulated academic setting.
Centre Hospitalier Universitaire (CHU) de Lyon
Accreditations:
National oversight by the French Ministry of Health
University-affiliated teaching hospital
Specializations:
Delivers comprehensive cancer care across hematologic and solid malignancies, supported by tertiary-care infrastructure and research activity.
Centre Hospitalier Universitaire (CHU) de Bordeaux
Accreditations:
National oversight by the French Ministry of Health
University-affiliated teaching hospital
Specializations:
Offers oncology and hematology services within a multidisciplinary academic environment, including advanced diagnostics and systemic therapies.
Hôpital de la Timone, Marseille
Accreditations:
National oversight by the French Ministry of Health
University-affiliated teaching hospital
Specializations:
Provides hematology oncology care for complex conditions, supported by specialized units, imaging, and multidisciplinary clinical teams.
| Procedure Type | Estimated Cost Range (USD) |
| Chemotherapy (per cycle) | $2,000-$8,000 |
| Immunotherapy (per cycle) | $4,000-$12,000 |
| Targeted Therapy (per cycle) | $3,000-$10,000 |
| Radiation Therapy (course) | $7,000-$18,000 |
| Bone Marrow Transplantation | $40,000-$90,000 |
| Diagnostic Oncology Workup | $2,500-$6,000 |
Note: The prices listed above are approximate, non-binding estimates provided for general informational purposes only. Actual treatment costs may vary based on individual clinical requirements, diagnostic findings, treatment complexity, materials or technology used, physician expertise, facility type, and duration of care. Final pricing is determined only after a professional evaluation by a licensed specialist or accredited medical institution.
France’s hematology oncology system is grounded in strong national regulation, patient safety frameworks, and institutional accountability. Specialist training standards are uniformly regulated, supporting consistent quality of cancer care across institutions. Evidence-based medicine, informed consent, and comprehensive clinical documentation are central to oncology practice.
Advanced medical technology is integrated within regulated care pathways, including molecular diagnostics, precision imaging, and modern systemic therapies. National oversight mechanisms reinforce transparency and ethical medical tourism principles, ensuring that care delivery prioritizes patient safety and professional responsibility.
Practical considerations and limitations
International patients may encounter eligibility criteria, administrative requirements, or extended treatment timelines depending on the type of cancer therapy. Length of stay, need for repeat visits, language support availability, and coordination with home-country oncologists are practical factors that often influence care planning. Understanding these elements in advance can help patients feel informed and supported when considering treatment abroad.
Best Clinic Abroad is a medical travel facilitator that supports patients seeking information and coordination for hematology oncology care in France. It is not a medical provider and does not offer diagnosis, treatment recommendations, or clinical opinions. All medical decisions are made exclusively by licensed hematologists, oncologists, and accredited hospitals.
➤ Hospital coordination - Support communication and coordination with accredited hospitals
➤ Appointment support - Assist with scheduling and organizing consultations
➤ Communication assistance - Help patients understand next steps without replacing medical advice
➤ Logistical guidance - Offer non-clinical support related to travel planning
Patients who wish to explore their options may choose to engage with Best Clinic Abroad to better understand administrative steps and coordination pathways involved in cancer care.
Which country is best for blood cancer treatment?
There is no single country universally considered the best for blood cancer treatment. Many countries, including France, are recognized for regulated healthcare systems, specialist training, and access to advanced diagnostics and therapies, and suitability depends on individual clinical needs.
How much does cancer treatment cost in France?
Cancer treatment costs in France vary widely depending on the type of cancer, treatment modality, duration of care, and clinical complexity. You will typically receive cost ranges rather than fixed prices, with final costs determined after professional evaluation.
How many oncologists are there in France?
France has several thousand practicing oncologists and hematologists working across public hospitals, cancer centers, and private practice. Exact numbers change over time due to training cycles and workforce planning, but oncology is a well-established specialty within the national healthcare system.
Disclaimer: This content is provided for informational purposes only and does not constitute medical advice. It reflects non-clinical observation of healthcare coordination processes and institutional practices in France and does not represent direct medical practice. Diagnosis and treatment decisions should always be made in consultation with a licensed medical specialist based on individual clinical evaluation.
Last updated: February 2026
.avif&w=3840&q=75)
